Standout Papers

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection 2011 2026 2016 2021 607
  1. Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection (2011)
    Timothy R. Sterling, Margarita E. Villarino et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Global trends in antibiotic consumption during 2016–2023 and future projections through 2030
2024 Standout
Drug-resistant tuberculosis: a persistent global health concern
2024 Standout
3 intermediate papers

Works of Amy Kerrigan being referenced

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
2011 Standout

Author Peers

Author Last Decade Papers Cites
Amy Kerrigan 677 364 553 7 737
Kai Kliiman 614 269 529 12 700
Jacinta Munro 522 329 419 10 633
Alice Hafner 570 180 441 14 789
Ruth N. Moro 642 311 527 19 814
Grace L. Barnes 630 253 520 22 733
R. Williams 440 213 412 5 730
Kemal Tahaoğlu 491 303 371 15 661
Kenneth R. Ong 620 284 539 8 740
Munira Khan 643 266 507 14 829
Philip C. Slocum 413 182 328 13 599

All Works

Loading papers...

Rankless by CCL
2026